Dr. Scholz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4560 Admiralty Way
Ste 111
Marina Del Rey, CA 90292Phone+1 310-827-7707Fax+1 310-574-4002
Education & Training
- University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 1986 - 1988
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1983 - 1986
- Creighton University School of MedicineClass of 1983
Certifications & Licensure
- CA State Medical License 1984 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Most Compassionate Doctor American Registry
Clinical Trials
- Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T Start of enrollment: 2012 Oct 01
- Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- 15 citationsGermline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy.Joanne Weidhaas, Nicholas Marco, Aaron W Scheffler, Anusha Kalbasi, Kirk Wilenius
Journal for Immunotherapy of Cancer. 2022-02-01 - 17 citationsPhase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T.Tanya B. Dorff, Yosuke Hirasawa, Jared David Acoba, Ian Pagano, David Jon Tamura
Journal for Immunotherapy of Cancer. 2021-08-01 - 7 citationsReal World Experience With Pembrolizumab in Recurrent or Advanced Prostate Cancer.Julianna Higa, Kirk Wilenius, Shannon Savino, Claire Larsen, Mark C. Scholz
Clinical Genitourinary Cancer. 2020-08-01
Press Mentions
- Dr. Mark Scholz, MD., of Acclaimed Prostate Oncology Specialists Inc., Examines Treating Metastatic Prostate CancerMay 6th, 2022
- So, What’s so Special About Dr. Mark Scholz, MD., of Prostate Oncology Specialists Inc., and His Highly Esteemed Book?March 16th, 2022
- Dr. Mark Scholz, MD., of Prostate Oncology Specialists Inc., Examines Prostate Cancer Antibody Drug with Success in DogsFebruary 17th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: